technetium-tc-99m-medronate and Dysgerminoma

technetium-tc-99m-medronate has been researched along with Dysgerminoma* in 3 studies

Other Studies

3 other study(ies) available for technetium-tc-99m-medronate and Dysgerminoma

ArticleYear
Unusual Tc-99m MDP bone scan imaging in a case of skull angioma.
    Clinical nuclear medicine, 1999, Volume: 24, Issue:5

    Topics: Adult; Dysgerminoma; Female; Hemangioma; Humans; Neoplasms, Multiple Primary; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Skull; Skull Neoplasms; Technetium Tc 99m Medronate

1999
Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1993, Volume: 27, Issue:1

    Reduced uptake of 99mTc-methylene bisphosphonate (99mTc-MBP) was found in irradiated bone in all of 13 tumour-free patients who had undergone radiotherapy (30-40 Gy) due to seminoma 3-8 years prior to bone scintigraphy. Decreased uptake of 99mTc phosphate compounds can not per se be interpreted as a sign of absence of metastases or reduced tumour burden.

    Topics: Acetabulum; Adult; Aorta; Dysgerminoma; Humans; Lumbar Vertebrae; Lymph Nodes; Middle Aged; Radionuclide Imaging; Spinal Neoplasms; Technetium Tc 99m Medronate; Thoracic Vertebrae

1993
Horseshoe kidney simulation by paraaortic metastases from a testicular tumor.
    Clinical nuclear medicine, 1987, Volume: 12, Issue:1

    Topics: Adult; Diagnosis, Differential; Dysgerminoma; Humans; Kidney; Kidney Neoplasms; Male; Radionuclide Imaging; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Teratoma; Testicular Neoplasms

1987